Cargando…
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine
Longitudinal data on the immune response from the first dose to several months after the third dose of COVID-19 vaccine are limited. We analyzed the immune response in 406 Japanese healthcare workers who received at least three doses of vaccine. The geometric mean anti-receptor binding domain IgG an...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887493/ https://www.ncbi.nlm.nih.gov/pubmed/36732167 http://dx.doi.org/10.1016/j.vaccine.2023.01.049 |
_version_ | 1784880351433195520 |
---|---|
author | Uwamino, Yoshifumi Yokoyama, Takashi Sato, Yasunori Shibata, Ayako Kurafuji, Toshinobu Tanabe, Akiko Noguchi, Masayo Arai, Tomoko Ohno, Akemi Yokota, Hiromitsu Namkoong, Ho Nishimura, Tomoyasu Kosaki, Kenjiro Hasegawa, Naoki Wakui, Masatoshi Murata, Mitsuru Matsushita, Hiromichi |
author_facet | Uwamino, Yoshifumi Yokoyama, Takashi Sato, Yasunori Shibata, Ayako Kurafuji, Toshinobu Tanabe, Akiko Noguchi, Masayo Arai, Tomoko Ohno, Akemi Yokota, Hiromitsu Namkoong, Ho Nishimura, Tomoyasu Kosaki, Kenjiro Hasegawa, Naoki Wakui, Masatoshi Murata, Mitsuru Matsushita, Hiromichi |
author_sort | Uwamino, Yoshifumi |
collection | PubMed |
description | Longitudinal data on the immune response from the first dose to several months after the third dose of COVID-19 vaccine are limited. We analyzed the immune response in 406 Japanese healthcare workers who received at least three doses of vaccine. The geometric mean anti-receptor binding domain IgG antibody titers and antigen-stimulated T-cell interferon-gamma levels after 6 months after receiving a third dose were similar to those 8 weeks after receiving a second dose. Humoral and cellular immunity induced by the third dose was more durable than that induced by the second dose. UMIN Clinical Trials Registry ID: UMIN000043340. |
format | Online Article Text |
id | pubmed-9887493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98874932023-01-31 Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine Uwamino, Yoshifumi Yokoyama, Takashi Sato, Yasunori Shibata, Ayako Kurafuji, Toshinobu Tanabe, Akiko Noguchi, Masayo Arai, Tomoko Ohno, Akemi Yokota, Hiromitsu Namkoong, Ho Nishimura, Tomoyasu Kosaki, Kenjiro Hasegawa, Naoki Wakui, Masatoshi Murata, Mitsuru Matsushita, Hiromichi Vaccine Short Communication Longitudinal data on the immune response from the first dose to several months after the third dose of COVID-19 vaccine are limited. We analyzed the immune response in 406 Japanese healthcare workers who received at least three doses of vaccine. The geometric mean anti-receptor binding domain IgG antibody titers and antigen-stimulated T-cell interferon-gamma levels after 6 months after receiving a third dose were similar to those 8 weeks after receiving a second dose. Humoral and cellular immunity induced by the third dose was more durable than that induced by the second dose. UMIN Clinical Trials Registry ID: UMIN000043340. Elsevier Ltd. 2023-02-24 2023-01-31 /pmc/articles/PMC9887493/ /pubmed/36732167 http://dx.doi.org/10.1016/j.vaccine.2023.01.049 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Uwamino, Yoshifumi Yokoyama, Takashi Sato, Yasunori Shibata, Ayako Kurafuji, Toshinobu Tanabe, Akiko Noguchi, Masayo Arai, Tomoko Ohno, Akemi Yokota, Hiromitsu Namkoong, Ho Nishimura, Tomoyasu Kosaki, Kenjiro Hasegawa, Naoki Wakui, Masatoshi Murata, Mitsuru Matsushita, Hiromichi Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title | Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title_full | Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title_fullStr | Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title_full_unstemmed | Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title_short | Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine |
title_sort | humoral and cellular immune response dynamics in japanese healthcare workers up to six months after receiving a third dose of bnt162b2 monovalent vaccine |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887493/ https://www.ncbi.nlm.nih.gov/pubmed/36732167 http://dx.doi.org/10.1016/j.vaccine.2023.01.049 |
work_keys_str_mv | AT uwaminoyoshifumi humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT yokoyamatakashi humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT satoyasunori humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT shibataayako humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT kurafujitoshinobu humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT tanabeakiko humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT noguchimasayo humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT araitomoko humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT ohnoakemi humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT yokotahiromitsu humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT namkoongho humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT nishimuratomoyasu humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT kosakikenjiro humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT hasegawanaoki humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT wakuimasatoshi humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT muratamitsuru humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine AT matsushitahiromichi humoralandcellularimmuneresponsedynamicsinjapanesehealthcareworkersuptosixmonthsafterreceivingathirddoseofbnt162b2monovalentvaccine |